Biocon’s state-of-the-art manufacturing facilities are qualified by various regulatory agencies from developed and emerging markets. A culture of quality excellence has helped us maintain a strong compliance track record in regulatory inspections over the years. Our Quality Control and Quality Assurance teams ensure that the cGMP guidelines, protocols and SOPs are implemented to deliver high quality products every time. Good Manufacturing Practices, Good Laboratory Practices and Good Documentation Practices are entrenched throughout our operations. The focus is on getting it right the first time. Robust regulatory and quality systems provide us the platform to develop and deliver complex therapeutics, lending us a significant global competitive advantage. Our strong regulatory, quality and manufacturing capabilities have ensured continued global acceptance of our complex small molecules and biosimilar products.